A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy Participants

NCT04453189 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: JNJ-64417184
DRUG: Lansoprazole
DRUG: Famotidine

Sponsor

Janssen Research & Development, LLC